Literature DB >> 28069869

Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry.

David M Andrenyak1, David E Moody1, Matthew H Slawson1, Daniel S O'Leary2, Margaret Haney3.   

Abstract

Two marijuana compounds of particular medical interest are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). A gas chromatography-tandem mass spectrometry (GC-MS-MS) method was developed to test for CBD, THC, hydroxy-THC (OH-THC) and carboxy-THC (COOH-THC) in human plasma. Calibrators (THC and OH-THC, 0.1 to 100; CBD, 0.25 to 100; COOH-THC, 0.5-500 ng/mL) and controls (0.3, 5 and 80 ng/mL, except COOH-THC at 1.5, 25 and 400 ng/mL) were prepared in blank matrix. Deuterated (d3) internal standards were added to 1-mL samples. Preparation involved acetonitrile precipitation, liquid-liquid extraction (hexane:ethyl acetate, 9:1), and MSTFA derivatization. An Agilent 7890 A GC was interfaced with an Agilent 7000 MS Triple Quadrupole. Selected reaction monitoring was employed. Blood samples were provided from a marijuana smoking study (two participants) and a CBD ingestion study (eight participants). Three analytes with the same transitions (THC, OH-THC and COOH-THC) were chromatographically separated. Matrix selectivity studies showed endogenous chromatographic peak area ratios (PAR) at the analyte retention times were <20% of the analyte limit of quantitation PAR. The intra-assay accuracy ranged from 83.5% to 118% of target and the intra-run imprecision ranged from 2.0% to 19.1%. The inter-assay accuracy ranged from 90.3% to 104% of target and the inter-run imprecision ranged from 6.5% to 12.0%. Stability was established for 25 hours at room temperature, 207 days at -20°C, after three freeze-thaw cycles and for 26 days for rederivatized processed samples. After smoking marijuana predictable concentrations of THC, OH-THC and COOH-THC were seen; low concentrations of CBD were detected at early time points. In moderate users who had not smoked for at least 9 hours before ingesting an 800 mg oral dose of CBD, the method was sensitive enough to follow residual concentrations of THC and OH-THC; sustained COOH-THC concentrations over 50 ng/mL validated its higher analytical range.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28069869      PMCID: PMC5412026          DOI: 10.1093/jat/bkw136

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  52 in total

1.  Analysis of estrogenic hormones in municipal wastewater effluent and surface water using enzyme-linked immunosorbent assay and gas chromatography/tandem mass spectrometry.

Authors:  C H Huang; D L Sedlak
Journal:  Environ Toxicol Chem       Date:  2001-01       Impact factor: 3.742

Review 2.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

Review 3.  Cannabis for therapeutic purposes and public health and safety: a systematic and critical review.

Authors:  Sharon R Sznitman; Yuval Zolotov
Journal:  Int J Drug Policy       Date:  2014-09-17

Review 4.  Drug of abuse profile: cannabis.

Authors:  R T Jones
Journal:  Clin Chem       Date:  1987-10       Impact factor: 8.327

5.  Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users.

Authors:  Dayong Lee; Mateus M Bergamaschi; Garry Milman; Allan J Barnes; Regina H C Queiroz; Ryan Vandrey; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2015-10       Impact factor: 3.367

6.  Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.

Authors:  Erin L Karschner; Eugene W Schwilke; Ross H Lowe; W David Darwin; Ronald I Herning; Jean Lud Cadet; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2009-10       Impact factor: 3.367

7.  Simultaneous determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy- Delta9-tetrahydrocannabinol in human plasma by high-performance liquid chromatography/tandem mass spectrometry.

Authors:  Barbora Maralikova; Wolfgang Weinmann
Journal:  J Mass Spectrom       Date:  2004-05       Impact factor: 1.982

8.  Validated method for the simultaneous determination of Delta9-THC and Delta9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography-mass spectrometry with electrospray ionization.

Authors:  Helena Teixeira; Alain Verstraete; Paula Proença; Francisco Corte-Real; Paula Monsanto; Duarte Nuno Vieira
Journal:  Forensic Sci Int       Date:  2007-07-05       Impact factor: 2.395

9.  Quantitative measurement of delta 9-tetrahydrocannabinol and two major metabolites in physiological specimens using capillary column gas chromatography negative ion chemical ionization mass spectrometry.

Authors:  R L Foltz; K M McGinnis; D M Chinn
Journal:  Biomed Mass Spectrom       Date:  1983-05

10.  Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration.

Authors:  João W Silveira; Ana Carolina Issy; Vitor A Castania; Carlos E G Salmon; Marcello H Nogueira-Barbosa; Francisco S Guimarães; Helton L A Defino; Elaine Del Bel
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

View more
  7 in total

1.  Marijuana-derived cannabinoids inhibit uterine endometrial stromal cell decidualization and compromise trophoblast-endometrium cross-talk.

Authors:  Naveen K Neradugomma; Kaitlyn Drafton; Gil G Mor; Qingcheng Mao
Journal:  Reprod Toxicol       Date:  2019-05-30       Impact factor: 3.143

2.  The effects of prenatal nicotine and THC E-cigarette exposure on motor development in rats.

Authors:  S Hussain; K R Breit; J D Thomas
Journal:  Psychopharmacology (Berl)       Date:  2022-03-26       Impact factor: 4.415

3.  A Model of Combined Exposure to Nicotine and Tetrahydrocannabinol via Electronic Cigarettes in Pregnant Rats.

Authors:  Kristen R Breit; Cristina G Rodriguez; Samirah Hussain; Karen J Thomas; Mikayla Zeigler; Ioanna Gerasimidis; Jennifer D Thomas
Journal:  Front Neurosci       Date:  2022-03-16       Impact factor: 4.677

4.  Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic Survey.

Authors:  Susan Mohamed; Giovanna Lopane; Loredana Sabattini; Cinzia Scandellari; Diletta Zardi; Vincenzo Donadio; Giovanni Rizzo; Alessandro Perrone; Alessandra Lugaresi; Manuela Contin
Journal:  Front Neurol       Date:  2022-03-24       Impact factor: 4.003

5.  Effects of prenatal alcohol and delta-9-tetrahydrocannabinol exposure via electronic cigarettes on motor development.

Authors:  Kristen R Breit; Cristina G Rodriguez; Annie Lei; Samirah Hussain; Jennifer D Thomas
Journal:  Alcohol Clin Exp Res       Date:  2022-07-26       Impact factor: 3.928

6.  Dronabinol Prescribing and Exposure Among Children and Young Adults Diagnosed with Cancer.

Authors:  Joseph E Rower; Amber D King; Diana Wilkins; Jacob Wilkes; Venkata Yellepeddi; Luke Maese; Richard S Lemons; Jonathan E Constance
Journal:  J Adolesc Young Adult Oncol       Date:  2020-07-14       Impact factor: 2.223

7.  Combined vapor exposure to THC and alcohol in pregnant rats: Maternal outcomes and pharmacokinetic effects.

Authors:  Kristen R Breit; Cristina G Rodriguez; Annie Lei; Jennifer D Thomas
Journal:  Neurotoxicol Teratol       Date:  2020-10-18       Impact factor: 3.763

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.